Intra Cranial EEG Activity During Dexmedetomidine Sedation

This study is not yet open for participant recruitment.
Verified July 2012 by University Health Network, Toronto
Sponsor:
Information provided by (Responsible Party):
University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT01648959
First received: July 13, 2012
Last updated: July 23, 2012
Last verified: July 2012

July 13, 2012
July 23, 2012
July 2012
May 2014   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01648959 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Intra Cranial EEG Activity During Dexmedetomidine Sedation
Intra Cranial EEG Activity During Dexmedetomidine Sedation.Comparing the Effects of Dexmedetomidine on the Cortical and the Sub Cortical(Hippocampus) Structures.

Various parts of the brain are sensitive to various anesthetics.We like to study the effect of dexmedetomidine on the different parts of the brain in patients who are coming for DBS electrode removal under sedation.

Cortical and sub cortical structures will have different sensitivities to various anesthetics.The objective of this study is to look at the changes in the intracranial electroencephalographic (EEG) characteristics during dexmedetomidine sedation and to determine the differences in the EEG characteristics between cortical and subcortical structures.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

Adults between 18 to 80 years of age, who are scheduled for elective removal of intracranial (surface and depth) electrodes under conscious sedation

EEG Effect of Dexmedetomidine on the Cortical and Subcortical Structures
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
20
May 2014
May 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Adults between 18 to 80 years of age, who are scheduled for elective removal of intracranial (surface and depth) electrodes under conscious sedation

Exclusion Criteria:

  • Lack of informed consent
  • Hypersensitivity to dexmedetomidine
  • Language barrier
  • Emergency surgery
Both
18 Years to 80 Years
No
Contact: Lashmikumar venkatraghavan, MD 416-603 ext 5800 Lashmi.Venkatraghavan@uhn.ca
Contact: Pirjo Manninen, MD 416-603 ext 5118 Prijo.Manninen@uhn.ca
Canada
 
NCT01648959
12-0268-B
No
University Health Network, Toronto
University Health Network, Toronto
Not Provided
Principal Investigator: lashmikumar venkatraghavan, MD Assistant professor,Toronto western hospital,university health network (UHN)
University Health Network, Toronto
July 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP